Skip to main content
RNA logo

RNA · Atrium Therapeutics, Inc. · Debt

Track RNA — free
$8.25 +0.20 (+2.48%)
Market Cap
$137.70M
Shares
17.11M
Volume · Oct 27 61.96K Avg daily vol (3M) 264.95K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 1,683,000 10-Q filed 2026-08-13
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 2093101 CUSIP 04965N104 13F (30d) 13 filings 13 filers Visit website Investor relations